University of Chicago Comer Children's Hospital — Chicago, Illinois

University of Chicago Comer Children's Hospital is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Chicago Comer Children's Hospital has participated in 36 clinical trials with 9 currently active.

Therapeutic areas: Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma.

Sponsors: New Approaches to Neuroblastoma Therapy Consortium, National Cancer Institute (NCI), Boston Children's Hospital.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago Comer Children's Hospital?

University of Chicago Comer Children's Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago Comer Children's Hospital conducted?

University of Chicago Comer Children's Hospital has 36 clinical trials on record, with 9 currently active. Their work covers Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma.

Is University of Chicago Comer Children's Hospital accredited by Crixeo Clinical Trials?

University of Chicago Comer Children's Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago Comer Children's Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.